Terms: = Germ cell tumor AND AFF3, MLLT2-like, 3899, ENSG00000144218, LAF4, P51826
5 results:
1. Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study.
Fukuoka K; Kurihara J; Shofuda T; Kagawa N; Yamasaki K; Ando R; Ishida J; Kanamori M; Kawamura A; Park YS; Kiyotani C; Akai T; Keino D; Miyairi Y; Sasaki A; Hirato J; Inoue T; Nakazawa A; Koh K; Nishikawa R; Date I; Nagane M; Ichimura K; Kanemura Y
Acta Neuropathol Commun; 2023 Sep; 11(1):153. PubMed ID: 37749662
[TBL] [Abstract] [Full Text] [Related]
2. Multiplexed Quantification of Four Neuroblastoma DNA Targets in a Single Droplet Digital PCR Reaction.
Peitz C; Sprüssel A; Linke RB; Astrahantseff K; Grimaldi M; Schmelz K; Toedling J; Schulte JH; Fischer M; Messerschmidt C; Beule D; Keilholz U; Eggert A; Deubzer HE; Lodrini M
J Mol Diagn; 2020 Nov; 22(11):1309-1323. PubMed ID: 32858250
[TBL] [Abstract] [Full Text] [Related]
3. Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions.
Piepkorn MW; Longton GM; Reisch LM; Elder DE; Pepe MS; Kerr KF; Tosteson ANA; Nelson HD; Knezevich S; Radick A; Shucard H; Onega T; Carney PA; Elmore JG; Barnhill RL
JAMA Netw Open; 2019 Oct; 2(10):e1912597. PubMed ID: 31603483
[TBL] [Abstract] [Full Text] [Related]
4. Elucidation of the genetic and epigenetic landscape alterations in RNA binding proteins in glioblastoma.
Bhargava S; Patil V; Mahalingam K; Somasundaram K
Oncotarget; 2017 Mar; 8(10):16650-16668. PubMed ID: 28035070
[TBL] [Abstract] [Full Text] [Related]
5. Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study.
Laverdière C; Liu Q; Yasui Y; Nathan PC; Gurney JG; Stovall M; Diller LR; Cheung NK; Wolden S; Robison LL; Sklar CA
J Natl Cancer Inst; 2009 Aug; 101(16):1131-40. PubMed ID: 19648511
[TBL] [Abstract] [Full Text] [Related]
